- Cosmos Pharmaceuticals (TYO: 3349) operates drug stores with a Walmart and 7-Eleven-like strategy, delivering industry leading growth (20% 10 year EBIT CAGR) over the past decade.
- The company’s larger than normal stores target small areas and resembles a neighborhood supermarket.
- At 18x EV/EBIT, Cosmos is a high quality business trading at an even higher price.
Continue reading “20% EBIT CAGR With A Walmart Twist – TYO: 3349 Cosmos Pharmaceuticals”
- I had the opportunity to spend a whole week with a Japanese executive chef.
- Through his work and careful explanation, the chef shared insights on thriving in the food industry.
- The chef’s approach largely incorporated the concept of intrinsic value, a core concept used in value investing.
Continue reading “Progress, Not Perfection – Lessons From A Japanese Executive Chef”
- Nitori (TYO: 9843) has delivered outstanding performance with a lovable story.
- Going above and beyond with its “high quality, affordable products” branding, Nitori is Japan’s most loved furniture brand.
- At 20x EV/EBIT, however, a considerable level of growth is already priced in. I’ll take another look if share price gets below 10,000 yen vs. today’s 16 ~ 17,000 yen.
Continue reading “Idea: Japan’s American-inspired IKEA competitor going global – Nitori Holdings (TYO: 9843)”
- Nihon Decoluxe’s (NGO: 7950) story is profitable, but as boring as it gets.
- Revenues have only slightly increased over the past 10 years while EBIT delivered 20% CAGR.
- At 0.37x EV/EBIT and a 3.5+% dividend yield, it’s hard to go wrong with Nihon Decoluxe.
Continue reading “Quick Idea: 101% NCAV With 3.5+% Dividend Yield On Consistent Performance – Nihon Decoluxe (NGO: 7950)”
- What would a bottom-up approach to intrinsic value look like?
- Maslow’s hierarchy of needs helps us develop a better understanding of value.
- What are some of the characteristics of value and how does it relate to investing?
Continue reading “Thoughts on Value”